The same study showed that treatment with thiazole-5-cabaldehyde O- (3,4-dichlorobenzyl) oxime (CITCO), a CAR specific agonist, led to an impairment of anti-cancer agent action as well as inhibition of cancer cell apoptosis (4). This evidence concerns the gene NR1I3 and cancer.